Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
Leading Pediatrics Hospital Finds Rapid Testing Reduces Unnecessary Use of Antibiotics
In a five-year study, VERIGENE® BC-GP Test shrinks time to results by as much as 24 hours
In a new publication, medical professionals from Children’s Hospital Los Angeles and the University of Southern California report results from a comprehensive five-year study of the VERIGENE® Gram-Positive (BC-GP) Blood Culture Test. They found that the “[VERIGENE] BC-GP panel demonstrated excellent performance” and that its reliable detection of genes conferring drug resistance allows healthcare providers to “confidently de-escalate antimicrobial therapy” when appropriate, according to the paper.
Continue Reading >
xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.